In addition, several clinical studies have analyzed the relationship between blood levels of the soluble form of PD-1 and the clinicopathological characteristics in cancer patients, demonstrating that this form of PD-1 can be used as a predictive factor [165,166]. The gene discussed is PDCD1; the disease is cancer.